Neuronlogica
ActiveSummary
Neuronlogica has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €97,951 and a net result of €95,951. Equity is growing by ~40.1% per year across the filed fiscal years. Its solvency ranks better than 29% of 19922 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability100=
Solvency68▲+7
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8,000 at 30 days acceptable
Liquidity ample (current ratio 1.51 against 1.51 in 2023; short-term debt: 36.5% and cash: 36.6% of total assets), but 57.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
31 d early
2024
28 d early
2023
17 d early
2022
26 d early
2021
27 d early
2020
23 d early
2019
25 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 25 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 4 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€97,951▼ 6.4%
2023 · €104,695
Total assets
€230,369▼ 20.6%
2023 · €290,168
Net result
€95,951▲ 24.0%
2023 · €77,385
Working capital
€43,191▼ 19.4%
2023 · €53,584
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€37,532€45,733▲ 21.8%€47,216▲ 3.2%€100,348▲ 113%€126,272▲ 25.8%
Net result€30,454within the sector's middle half€32,959within the sector's middle half▲ 8.2%€34,178within the sector's middle half▲ 3.7%€77,385within the sector's middle half▲ 126%€95,951within the sector's middle half▲ 24.0%
Equity€20,174below the sector's middle half€53,132below the sector's middle half▲ 163%€87,310within the sector's middle half▲ 64.3%€104,695within the sector's middle half▲ 19.9%€97,951within the sector's middle half▼ 6.4%
Total assets€238,465within the sector's middle half▲ 10.6%€261,927within the sector's middle half▲ 9.8%€257,395within the sector's middle half▼ 1.7%€290,168within the sector's middle half▲ 12.7%€230,369within the sector's middle half▼ 20.6%
Debt€218,291▼ 3.4%€208,795▼ 4.4%€170,085▼ 18.5%€185,474▲ 9.0%€132,418▼ 28.6%
Working capital-€18,167below the sector's middle half▲ 58.1%€2,490below the sector's middle half€38,646within the sector's middle half▲ 1,452%€53,584within the sector's middle half▲ 38.7%€43,191within the sector's middle half▼ 19.4%
Solvency8.5%below the sector's middle half▲ 13.2pp20.3%below the sector's middle half▲ 11.8pp33.9%below the sector's middle half▲ 13.6pp36.1%within the sector's middle half▲ 2.2pp42.5%within the sector's middle half▲ 6.4pp
Current ratio0.74below the sector's middle half▲ 0.541.04below the sector's middle half▲ 0.291.68within the sector's middle half▲ 0.641.51within the sector's middle half▼ 0.171.51within the sector's middle half=
Return on assets (ROA)12.8%within the sector's middle half▲ 18.5pp12.6%within the sector's middle half▼ 0.2pp13.3%within the sector's middle half▲ 0.7pp26.7%within the sector's middle half▲ 13.4pp41.7%above the sector's middle half▲ 15.0pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2024 is 26% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €230,369
Fixed assets
€103,100 ▼ 21.9%
Current assets
€127,269 ▼ 19.6%
Equity and liabilities €230,369
Equity
€97,951 ▼ 6.4%
Debt
€132,418 ▼ 28.6%
Debt's share of the balance-sheet total falls from 63.9% to 57.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
€155,132▲
2023 · €130,107
Cash flow
€124,811▲
2023 · €107,144
Debt to equity
1.35▼
2023 · 1.77
ROE
98.0%▲
2023 · 73.9%
Interest coverage
144.93▲
2023 · 94.32
Debt ≤ 1 year
€84,077▼
2023 · €104,624
Debt > 1 year
€48,340▼
2023 · €80,850
Income taxes
€29,251▲
2023 · €21,584
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €25,167 | €34,319 | €33,884 | €29,759 | €28,860 | ▼ 3.0% |
| Other operating charges640/8 | - | €550 | €676 | €993 | €1,544 | ▲ 55.4% |
| Gross operating margin9900 | €63,247 | €80,602 | €81,776 | €131,100 | €156,676 | ▲ 19.5% |
| Operating profit (loss)9901 | €37,532 | €45,733 | €47,216 | €100,348 | €126,272 | ▲ 25.8% |
| Financial income75/76B | - | €52 | €2 | €0 | €0 | ▼ 100% |
| Recurring financial income75 | €23 | €52 | €2 | €0 | €0 | ▼ 100% |
| Financial charges65/66B | - | €2,048 | €1,687 | €1,379 | €1,070 | ▼ 22.4% |
| Recurring financial charges65 | €1,729 | €2,048 | €1,687 | €1,379 | €1,070 | ▼ 22.4% |
| Profit (loss) for the period before taxes9903 | €35,827 | €43,736 | €45,532 | €98,968 | €125,202 | ▲ 26.5% |
| Income taxes67/77 | €5,373 | €10,778 | €11,354 | €21,584 | €29,251 | ▲ 35.5% |
| Profit (loss) for the period9904 | €30,454 | €32,959 | €34,178 | €77,385 | €95,951 | ▲ 24.0% |
| Profit (loss) for the period to be appropriated9905 | €30,454 | €32,959 | €34,178 | €77,385 | €95,951 | ▲ 24.0% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €238,465 | €261,927 | €257,395 | €290,168 | €230,369 | ▼ 20.6% |
| Fixed assets21/28 | €185,623 | €195,604 | €161,719 | €131,960 | €103,100 | ▼ 21.9% |
| Intangible fixed assets21 | €173,333 | €153,333 | €133,333 | €113,333 | €93,333 | ▼ 17.6% |
| Tangible fixed assets22/27 | €11,989 | €41,970 | €28,086 | €18,327 | €9,467 | ▼ 48.3% |
| Land and buildings22 | - | €2,798 | €0 | - | - | - |
| Furniture and vehicles24 | - | €39,172 | €27,187 | €18,327 | €9,467 | ▼ 48.3% |
| Other tangible fixed assets26 | - | - | €899 | €0 | - | - |
| Financial fixed assets28 | €300 | €300 | €300 | €300 | €300 | = |
| Current assets29/58 | €52,842 | €66,324 | €95,675 | €158,208 | €127,269 | ▼ 19.6% |
| Amounts receivable within one year40/41 | €1,000 | €1,222 | €3,771 | €2,668 | €2,692 | ▲ 0.9% |
| Trade receivables40 | - | €0 | €2,549 | €2,668 | €2,692 | ▲ 0.9% |
| Other amounts receivable41 | - | €1,222 | €1,222 | €0 | - | - |
| Cash at bank and in hand54/58 | €28,463 | €63,545 | €91,104 | €105,920 | €84,379 | ▼ 20.3% |
| Deferred charges and accrued income490/1 | - | €1,556 | €800 | €49,620 | €40,197 | ▼ 19.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €238,465 | €261,927 | €257,395 | €290,168 | €230,369 | ▼ 20.6% |
| Equity10/15 | €20,174 | €53,132 | €87,310 | €104,695 | €97,951 | ▼ 6.4% |
| Contributions10/11 | - | €2,000 | €2,000 | €2,000 | €2,000 | = |
| Reserves13 | €18,174 | €51,132 | €85,310 | €102,695 | €95,951 | ▼ 6.6% |
| Distributable reserves133 | - | €51,132 | €85,310 | €102,695 | €95,951 | ▼ 6.6% |
| Profit (loss) carried forward14 | €0 | - | - | €0 | €0 | - |
| Amounts payable17/49 | €218,291 | €208,795 | €170,085 | €185,474 | €132,418 | ▼ 28.6% |
| Amounts payable after more than one year17 | €147,282 | €144,961 | €113,056 | €80,850 | €48,340 | ▼ 40.2% |
| Financial debts170/4 | - | €144,961 | €113,056 | €80,850 | €48,340 | ▼ 40.2% |
| Amounts payable within one year42/48 | €71,009 | €63,834 | €57,029 | €104,624 | €84,077 | ▼ 19.6% |
| Current portion of amounts payable after more than one year42 | - | €31,608 | €31,905 | €32,206 | €32,509 | ▲ 0.9% |
| Trade debts44 | €2,052 | €309 | €2,346 | €1,924 | €569 | ▼ 70.4% |
| Suppliers440/4 | - | €309 | €2,346 | €1,924 | €569 | ▼ 70.4% |
| Taxes, remuneration and social security45 | - | €0 | €3,464 | €9,571 | €15,785 | ▲ 64.9% |
| Taxes450/3 | - | €0 | €1,354 | €7,334 | €15,785 | ▲ 115% |
| Remuneration and social security454/9 | - | €0 | €2,110 | €2,237 | €0 | ▼ 100% |
| Other amounts payable47/48 | - | €31,918 | €19,314 | €60,923 | €35,214 | ▼ 42.2% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €30,454 | €32,959 | €34,178 | €77,385 | €95,951 | ▲ 24.0% |
| + Depreciation and write-downs630 | €25,167 | €34,319 | €33,884 | €29,759 | €28,860 | ▼ 3.0% |
| Operating cash flow (approximation) | €55,621 | €67,278 | €68,062 | €107,144 | €124,811 | ▲ 16.5% |
| Investment in fixed assets (approximation) | - | -€44,300 | €0 | €0 | €0 | - |
| Change in cash | - | €35,082 | €27,559 | €14,816 | -€21,541 | ▼ 245% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2019net €95,951 ▲24%
Operating result €126,272, net result €95,951, both a record.
14-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €100,000Eq €104,695 ▲19.9%
4 profitable years in a row build equity to €104,695.
05-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
04-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
08-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Back to profitnet €30,454
Net result €30,454 after one loss-making year.
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Boom · 2 establishment units since 2019
Ground area
12.7 ha
Building footprint
1.3 ha
Volume, LiDAR
946 m³
2 parcels, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Neuronlogica
since 20192.293.454.538
Neuronlogica
since 20192.293.454.637
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11812M0321/00A002 | Flanders | 12.6 ha | 1 · 1.3 ha | - |
| 11622C0642/00C002 | Flanders | 1,030 m² | 1 · 143 m² | 9.5 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
KINDERARTS KAÏRET
BE 0748.698.161
Lille · Eq €98,000
DRS. TOKA
BE 0719.505.616
Heusden-Zolder · Eq €98,004
MUSETTE SOPHIE
BE 0820.263.474
Ukkel · Eq €98,023
DR MIKEL NAKOUTSI
BE 0769.929.778
Braine-l'Alleud · Eq €98,063
Uvea
BE 0751.577.675
Tienen · Eq €97,764
Of 16,627 companies in sector 86220 we hold annual accounts for 7,986. 6,278 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded09-09-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
72109Other research and development on natural sciences
Contact
E-mail
wendy.vandaele@skynet.be
Phone
032802551
E-invoicing
Reachable via Peppol
Peppol ID
0208:0733819450
Also
9925:BE0733819450
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.